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Abstract
Background: Observational studies suggested an association between diabetes and the risk of various geriatric conditions
(i.e., cognitive impairment, dementia, depression, mobility impairment, disability, falls, and urinary incontinence). However,
the magnitude and impact of diabetes on older adults have not been reviewed.
Methodology/Principal Findings: MEDLINE and PSYCINFO databases were searched through November 2007 for published
studies, supplemented by manual searches of bibliographies of key articles. Population-based, prospective cohort studies
that reported risk of geriatric outcomes in relation to diabetes status at baseline were selected. Two authors independently
extracted the data, including study population and follow-up duration, ascertainment of diabetes status at baseline,
outcomes of interest and their ascertainment, adjusted covariates, measures of association, and brief results. Fifteen studies
examined the association of DM with cognitive dysfunction. DM was associated with a faster decline in cognitive function
among older adults. The pooled adjusted risk ratio (RR) for all dementia when persons with DM were compared to those
without was 1.47 (95% CI, 1.25 to 1.73). Summary RRs for Alzheimer’s disease and vascular dementia comparing persons
with DM to those without were 1.39 (CI, 1.16 to 1.66) and 2.38 (CI, 1.79 to 3.18), respectively. Four of 5 studies found
significant association of DM with faster mobility decline and incident disability. Two studies examined the association of
diabetes with falls in older women. Both found statistically significant associations. Insulin users had higher RR for recurrent
falls. One study for urinary incontinence in older women found statistically significant associations. Two studies for
depression did not suggest that DM was an independent predictor of incident depression.
Conclusions/Significance: Current evidence supports that DM is associated with increased risk for selected geriatric
conditions. Clinicians should increase their awareness and provide appropriate care. Future research is required to elucidate
the underlying pathological pathway.
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Introduction
The prevalence and morbidities associated with DM continue to
increase among older adults, which impose a significant burden on
the health care system [1–3]. In addition to traditional vascular
complications, growing epidemiologic evidence has suggested that
DM could be independently associated with various aging
phenotypes, or so-called ‘‘geriatric syndromes’’, namely cognitive
impairment [4–6], dementia [7,8], depression [9,10], mobility
impairment or disability [11–14], falls [15], and urinary in-
continence [16,17]. These problems are highly prevalent in older
people, especially frail older adults. They have detrimental effects
on the quality of life, functional outcomes, and even mortality of
the elderly [18–20].
However, the temporal relationship between DM and geriatric
syndromes remained unanswered. A number of primary studies
assessing the association between diabetes and separate geriatric
outcomes had methodological flaws, such as a cross-sectional design
[13,21,22], problematic diabetic ascertainment [23,24], or inade-
quateconsiderationofpotentialconfounders[25].Inaddition,many
studies enrolled nursing home residents [26] or clinical trial
volunteers [27], thus having serious concerns of generalizability. A
few systematic reviews have focused on the effect of diabetes on
individualgeriatricoutcomes[28,29],buttheyalsopresentedseveral
weaknesses, such as inclusion of cross-sectional studies or those
without proper adjustment for major confounders.
We therefore conducted a systematic review and meta-analyses
of prospective population-based studies examining the association
between diabetes and the incidence of various geriatric conditions
to verify the impact of DM on community-dwelling older adults.
Methods
Searching
We searched MEDLINE (1950 to November 2007) and
PSYCINFO(1967toNovember2007)databasesusingcombination
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4144ofthefollowingterms,bothaskeywordsandmappedtoMeSHterms
withexplosion when possible: ‘‘cognitive impairment’’, ‘‘cognition’’,
‘‘cognition disorders’’, ‘‘dementia’’, ‘‘depression’’, ‘‘depressive
symptoms’’, ‘‘depressive disorder’’, ‘‘walking’’, ‘‘musculoskeletal
equilibrium’’, ‘‘mobility limitation’’, ‘‘physical function’’, ‘‘activities
of daily living’’, ‘‘disability evaluation’’, ‘‘disabled persons’’, ‘‘func-
tional decline’’, ‘‘accidental falls’’, and ‘‘urinary incontinence’’. To
identify prospective studies, we used the following index terms:
‘‘cohortstudies’’,‘‘risk’’,‘‘group’’,or‘‘incidence’’.Thenthesearches
were combined with ‘‘diabetes mellitus’’ and ‘‘aged’’. Additional
references were found by reviewing bibliographies from identified
articles. We considered articles published in any language.
Selection
Individual study had to meet the following inclusion criteria: (1)
population-based studies of community-dwelling older adults (i.e.
persons aged 60 and over); (2) examination of the prospective
effect of DM on individual geriatric syndrome; (3) DM being
ascertained by combination of medical history, use of anti-diabetic
medications, or laboratory tests (fasting glucose and/or glucose
tolerance test). Studies with DM ascertainment based on self-
reported history were excluded. To facilitate generalizability, we
excluded studies conducted in specific population including
hospital-based patients, institutionalized older adults, or pharma-
ceutical clinical trial volunteers. Mild cognitive impairment (MCI)
was not included in cognitive outcomes due to lack of consistent
diagnostic criteria. Studies without appropriate consideration or
adjustment for potential confounders, especially cardiovascular
confounders, were excluded.
Validity Assessment and Data Abstraction
Two of the authors independently examined all identified
articles. Following the Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) statement [30], we used a standardized
reporting form to abstract the following data and quality indicators
from each eligible study: first author and citation, country, study
design, study population and follow-up duration, ascertainment of
diabetes status at baseline, outcomes of interest and their
ascertainment, adjusted covariates, measures of association, and
brief results.
Quantitative Data Synthesis
Selected papers were grouped and examined based on
individual geriatric condition. A meta-analysis of studies was done
if the results were presented in the same, combinable format. Data
management and analysis were done using STATA version 9.0
software (Stata, College Station, Texas) and Review Manager 4.2
(The Cochrane Collaboration, Oxford, United Kingdom). We
used fixed-effects models and DerSimonian and Laird random-
effects models to calculate the pooled estimate across the studies.
The x-squared test was used to check for heterogeneity between
the studies. Meta-regression was performed to assess the effect of
several clinical factors on risk of geriatric outcomes. The possibility
of publication bias was assessed using Begg’s funnel plot and
Egger’s test. A careful qualitative appraisal was presented if the
results between studies could not be appropriately combined.
Results
Flow of included studies
Based on the database search strategies, 1994 citations were
retrieved. We identified 205 potentially relevant studies. Among
these, 25 studies met the predefined selection criteria. Figure 1
showed the search and selection process. There were 15 studies
included for an association between DM and cognitive dysfunc-
tion, two for depression, five for mobility impairment or disability,
two for falls, and one for urinary incontinence, respectively.
Cognitive Dysfunction
Changes in global cognition or individual cognitive
domain. Seven prospective studies that assessed the association
of DM and changes in cognitive performance (Table 1) have
suggested a causal role of DM in the development of cognitive
impairment [6,31–36]. Measures of cognitive function in these
studies included global cognition, such as Mini-Mental State
Examination (MMSE) and the Telephone Interview for Cognitive
Status(TICS),aswellasindividualcognitivedomains,suchastestsof
memory, visuospatial ability, and frontal executive functions.
Patients with DM were reported to have a faster decline in global
cognitivefunction,asreflectedbythescoresofMMSEorTICS,after
2–7 years of follow-up [33,35,36].
However, tests of global cognitive function may not be sensitive
enough to detect impairment in individual cognitive domains.
Frontal executive functions, measured by such tests as Trailmaking
B, Digit Symbol Substitution Test (DSST), and the word-list
generation (verbal fluency), were selectively impaired by increased
load of cardiovascular risk [37,38]. Prospective population-based
studies in our review consistently reported that baseline DM was
associated with a faster decline in measures of executive function
[6,31,32,34].
Two studies reported increased risk of cognitive decline with the
duration of diabetes [6,36]. One of the two studies examining the
association of insulin use and risk of cognitive decline suggested
a positive association [6]. One study found that the association
between diabetes and cognitive decline was attenuated by elevated
levels of glycohemoglobin [34].
In short, DM was associated with decline in cognitive, especially
executive, function. Although included studies had considered the
impact of cardiovascular covariates on the association between
DM and cognitive decline, not all studies had controlled for
depressive symptoms or the use of psychotropic agents. Future
studies should consider potential confounders and investigate the
role of glycemic control of cognitive function.
All dementia, Alzheimer’s disease (AD), and vascular
dementia (VaD). Eight original articles fulfilled the predefined
criteria (Table 2) [8,39–45]. All were prospective population-based
studies conducted in Canada, United States, or Europe, with
various follow-up periods ranging from 2.1 years to more than
10 years. Participants were older community-dwelling adults with
mean baseline age varied from 69 to 83 years.
Two studies [8,40] did not provide risk estimate for all
dementia. Results from the remaining six studies showed that
DM was associated with a higher risk for all dementia, yet not all
of them achieved statistical significance. The six studies used the
same format, namely, risk ratios (RRs), or hazard ratios (HRs) for
the risk of developing dementia for diabetes compared with non-
diabetes. Two studies using logistic regression for analysis [41,42].
The adjusted odds ratios (ORs) were considered as RRs since the
incidence of dementia were not common in the study population
[46]. In order to quantitatively analyze the results from various
studies and increase the statistical power, we performed a meta-
analysis to combine the reported results. Meta-analysis of the six
studies showed that, the overall RR for all dementia when persons
with DM were compared to those without was 1.47 (95% CI, 1.25
to 1.73) (Figure 2A). Test for heterogeneity using a x-squared test
showed a Q-test statistic of 3.269 with five degrees of freedom
(p=0.659), indicating that there was little evidence for heteroge-
neity among studies.
DM and Geriatric Syndromes
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diabetic patients had significantly higher risk of AD comparing to
those without DM [39,42]. Five studies reported increased, yet not
achieving statistical significance, risk of AD comparing persons
with DM to those without [8,41–43,45]. One study from Sweden
reported decreased risk, though not significant, for AD among
older diabetics [40]. It may be explained by many competing risks
for AD among the oldest cohort (mean age 83 years). On the other
hand, data reporting the association between DM and risk of VaD
were more consistent. Six studies reported that DM was
significantly associated with an increased risk of VaD [8,40–
43,45]. The other two negative findings had small statistical power
because relatively few cases of incident VaD were identified
[39,44]. Meta-analysis of the eight studies showed that the overall
RRs for AD and VaD comparing persons with DM to those
without were 1.39 (CI, 1.16 to 1.66, p,0.001) and 2.38 (CI, 1.79
to 3.18, p,0.001), respectively (Figure 2B, 2C). Test for
heterogeneity did not reveal significant heterogeneity among
studies.
A fixed effects model was selected for further meta-regression
because prior test for between-study heterogeneity was not
statistically significant. The meta-regressions showed no difference
in effects between either country (non-USA versus USA), age, sex
ratio, and study year on the risk of all dementia, AD, and VaD.
For tests of publication bias, visual inspection of the Begg’s funnel
plots for all dementia, AD, and VaD did not reveal asymmetry
(P.0.05). The Egger’s tests were not statistically significant.
None of the eight studies examined the association between
duration of diabetes and the risk of dementia. Five of the eight
studies had considered the association between diabetes medica-
tions and risk of dementia [39,41–44]. The results were
heterogeneous. Insulin use was related to higher risk of dementia
in two studies [39,41]. One study found no effect of treatment on
the risk of incident dementia [44]. Another study reported
increased risk of dementia was associated with use of oral anti-
diabetic medications [43].
In summary, we found that DM was associated with a 47%
increased risk for all dementia, 39% for Alzheimer’s dementia, and
Figure 1. Flow diagram of selection process.
doi:10.1371/journal.pone.0004144.g001
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PLoS ONE | www.plosone.org 3 January 2009 | Volume 4 | Issue 1 | e4144Table 1. Population-based prospective studies for the association between diabetes and changes in cognitive performance.
Source
Study
population
Mean age
at baseline, yr
Follow-up,
yr
Ascertainment
of diabetes
Ascertainment of
cognitive function Covariates
Results (diabetic
individuals had
faster decline in …)
Haan et al,
1999 [31]
5888 elders from
the Cardiovascular
Health Study
(CHS) (USA)
.65 5–7 Hx, Rec,
FG/OGTT
Modified MMSE, DSST Age, sex, race, incident
stroke, education
DSST
Gregg et al,
2000 [6]
9679 community-
dwelling elderly
white women
from the Study of
Osteoporotic
Fractures (SOF)
(USA)
72 3–6 Hx, Mx Modified MMSE, visuospatial/
motor speed of processing
(Trailmaking B, DSST)
Age, education,
depression, visual
impairment, stroke,
baseline score
Visuospatial/ motor
speed of processing
(Trails Making B and
DSST)
Fontbonne
et al, 2001
[32]
961 healthy
community-
dwelling elders
from the
Epidemiology of
Vascular Aging
(EVA) Study
(France)
65 4 Hx, Mx, FG MMSE, visual attention
(Trailmaking B), immediate
verbal memory (Auditory
Verbal Learning Test),
visuospatial processing (Test of
Facial Recognition), speed of
processing (DSST), psychomotor
speed (Finger Trapping Test),
immediate visual memory
(Benton Visual Retention Test),
logical reasoning (Raven’s
Progressive Matrixes), and
auditory attention (Paced
Auditory Serial Addition Test)
Age, sex, education,
baseline score, systolic
blood pressure, BMI
Finger Trapping Test
Wu et al,
2003 [33]
1789 older
Mexican
Americans from
the population-
based Sacramento
Area Latino Study
on Aging (SALSA)
project (USA)
71 2 Hx, Mx, FG Modified MMSE, and verbal
memory (Delayed Word-List
Recall Test)
Age, sex, education,
baseline cognitive
score, CES-D score,
acculturation,
hypertension
Modified MMSE score
and word-list test*
Kanaya et al,
2004 [34]
999 community-
dwelling white
adults enrolled in
the Rancho
Bernardo Study
(USA)
70.7 4 Hx, Mx, FG/OGTT MMSE, Verbal Fluency Test,
and Trailmaking B
Age, education, BDI
score, presence of
ApoE epsilon 4 allele,
baseline cognitive test
score, current estrogen
use for women
Verbal Fluency Test
(association in women
only)
Hassing et al,
2004 [35]
258 elderly
individuals from
the Origins of
Variance in the
Old-Old study
(OCTO-Twin
Study) (Sweden)
83 6 Rec, Mx MMSE Age, sex, education,
smoking, angina,
myocardial infarction,
CHF, stroke, TIA
MMSE score
Logroscino
et al, 2004
[36]
18999 elderly
women from the
Nurses’ Health
Study (USA)
74 2 Hx, Mx TICS, test of verbal fluency
(Animal Naming Test), delayed
recall of a 10 word list, digit
span backwards, and
immediate/delayed recall of
the East Boston memory test
Age, education, high
cholesterol and
hypertension, vitamin
E supplement, age at
menopause, BMI, smoking,
antidepressant use,
alcohol intake,
post-menopausal
hormone use, mental
health index, energy-
fatigue index, use of
aspirin, NSAIDs
TICS
*Logistic regression model revealed that baseline DM was a predictor of major cognitive decline, defined as a 9-point or greater decrease in scores on Modified MMSE, 4-
point or greater decrease in scores on the word-list test.
BDI indicates Beck Depression Inventory, BMI body mass index, CDR Clinical Dementia Rating, CES-D Center for Epidemiologic Studies Depression Scale, CHF chronic heart
failure,CNScentralnervoussystem,DSSTDigitSymbolSubstitutiontest,FGfastingglucosetest,Hxself-reporthistoryofdiabetesoraphysician’sdiagnosisofdiabetes,MMSE
Mini-MentalStatusExamination,Mxuseofanti-diabetesmedicationsincludinginsulin,NFGnon-fastingglucosetest,OGTToralglucosetolerancetest,Recdiabetesmellitus
ascertained from medical records, TIA transient ischemic attack, TICS Telephone Interview for Cognitive Status, WAIS Wechsler Adult Intelligence Scale.
doi:10.1371/journal.pone.0004144.t001
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DM and Geriatric Syndromes
PLoS ONE | www.plosone.org 5 January 2009 | Volume 4 | Issue 1 | e4144Figure 2. Adjusted relative risk for all dementia (A), Alzheimer’s disease (B), and vascular dementia (C) in older diabetic adults
compared with non-diabetics in prospective population-based studies.
doi:10.1371/journal.pone.0004144.g002
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PLoS ONE | www.plosone.org 6 January 2009 | Volume 4 | Issue 1 | e4144more than 2-fold risk for vascular dementia, among community-
dwelling older adults. The association of DM to dementia was
independent of cardiovascular comorbidities.
Depression
Two eligible prospective studies are heterogeneous in terms of
depression ascertainment (table 3) [47,48]. Therefore, meta-
analytic technique is not applicable. The longitudinal Zaragoza
Dementia and Depression (ZARADEMP) project in Spain
followed 4,803 community-dwelling older adults for 5 years
[47]. Major depressive disorder was diagnosed by psychiatric
diagnostic interview at 2- and 5-year follow-up. After controlling
for age and sex, patients with DM had an increased risk (OR,
1.42 [CI, 1.04 to 1.93]) of incident depressive disorder.
However, the associations attenuated after further adjustment
(OR, 1.28 [CI, 0.91 to 1.79]). Investigators from the Health
ABC Study followed 3,024 community-dwelling older adults for
a mean of 5.9 years [48]. They found that, after controlling for
basic demographics and life styles, DM was associated with
a 30% increased risk (OR, 1.31 [CI, 1.07 to 1.61]) of incident
depressed mood. Further adjustment for cardiovascular covari-
ates attenuated the association (OR, 1.21 [CI, 0.98 to 1.49]).
They found that the level of glycohemoglobin was independently
associated with increased risk of recurrent depressed mood, but
duration of DM and DM treatment did not have effect on the
risk of recurrent depressed mood [48].
Although both studies suggested that DM patients had an
increased risk for depression, the association diminished after
additional consideration of cardiovascular confounders, suggesting
that baseline DM was not independently associated with incident
depressive disorder. Depression is known for a chronic, relapsing
disorder in older adults with diabetes [49]. The two studies did not
consider depressive episodes between each follow-up interval, nor
did they provide information regarding depressive episodes prior
to study entry. The effect of DM on incident depression was
difficult to determine based on current literatures.
To explain the association between DM and depression
observed in cross-sectional studies, a reverse causal relationship
has been proposed. The notion that depression was an in-
dependent risk factor for DM, rather than a consequence of
having diabetes, was supported by a few prospective studies and
meta-analysis over the past decade [50–54]. Future prospective
studies with proper design to investigate the temporal relation
between DM and depression are mandated.
Mobility Impairment and Disability
We identified five studies that fulfilled the predefined criteria
(Table 4) [11,55–58]. Because the physical outcome measures and
format of results were heterogeneous, meta-analysis was not
performed.
Most of the studies suggested that DM was associated with
higher risk of mobility impairment and physical disability among
older adults. The two studies reporting changes in objective
physical performance measures were limited to older women
[11,55]. Result from the prospective Women’s Health and Aging
Study (WHAS) suggested that, during a 3-year period, women
with diabetes had significant greater decline (38% per year) in
objective physical performance, including walking speed, chair
stands, and balance test, than non-diabetics [11]. Forrest et al.
analyzed data from the Study of Osteoporotic Fractures (SOF) and
found that, over 10 years, diabetes patients had greater decline in
walking speed and ability to complete 5 chair stands, compared to
their non-diabetic counterparts [55].
In addition to objectively measured physical performance, DM
was associated with decline in self-reported functional outcomes.
Gregg and colleagues followed 8,344 older women in the SOF
cohort for more than 10 years, and suggested that patients with
DM had higher risk of inability to perform one or more major
functional tasks (walking 1/4 mile, climbing 10 steps, performing
household chores, shopping, and cooking meals) [56]. Data from
the WHAS showed that DM was associated with an increased risk
of mobility disability (RR, 1.63 [CI, 1.12 to 2.36]) and activities of
daily living (ADL) disability (RR, 2.18 [CI, 1.33 to 3.6]) over
3 years [11]. Another longitudinal study, the Sacramento Area
Latino Study on Aging (SALSA) that followed 1,789 older
Mexican Americans for 2 years, also found that diabetic patients
had higher annual rate of decline in ADL and instrumental
activities of daily living (IADL) [57]. On the contrary, investigators
from the Health ABC study followed 2,895 high-functioning older
adults for 3.5 years and found that DM was not associated with
incident mobility disability [58]. This negative result may be
explained, at least in part, by the enrollment of well-functioning
older adults at baseline and a relatively short follow-up period
(3.5 years).
Table 3. Prospective studies of diabetes as a risk factor for depression in community-dwelling older adults.
Source Study population
Mean age at
baseline, yr
Follow-up,
yr
Ascertainment
of diabetes
Ascertainment of
depression Covariates
Results, OR
(95% CI)
De Jonge et al,
2006 [47]
4803 community-dwelling
elders from the ZARADEMP
project (Spain)
73.5 5 Hx, Mx MDD by psychiatric
diagnostic interview at
2- and 5-yr follow-up
Age, sex, partner,
education, hypertension,
smoking, statin use, and
cognitive functioning
1.28 (0.91–1.79)
Maraldi et al,
2007 [48]
2522 community-dwelling
subjects from the Health,
Aging, and Body Composition
(Health ABC) study (USA)
73.6 5.9 Hx, Mx,
FG/OGTT
Antidepressant use at
follow-up or CESD-
10.=10
Age, sex, race, study
site, baseline CES-D
score, hypertension,
cerebrovascular disease,
ankle-brachial index,
obesity, cystatin-C level,
IL-6 levels, 6-m walking
speed, and cognitive
functioning
1.21 (0.98–1.49)
CESD-10 indicates a 10-item subset of the standard Centre for Epidemiologic Studies Depression Scale, FG fasting glucose test, Hx self-report history of diabetes or
a physician’s diagnosis of diabetes, IL-6 interleukin-6, MDD major depressive disorder, Mx anti-diabetes medications including insulin, OGTT oral glucose tolerance test,
Rec diabetes mellitus ascertained from medical records, RR risk ratio.
doi:10.1371/journal.pone.0004144.t003
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PLoS ONE | www.plosone.org 7 January 2009 | Volume 4 | Issue 1 | e4144Three studies examined the association between duration of
diabetes and risk of functional decline [11,56–57]; two of them
found significant associations [11,57]. One study reported that
insulin use was not significantly associated with a higher risk of
incident functional decline [56]. One study found that the risk
of incident disability associated with diabetes was signifi-
cantly attenuated after adjustment for levels of glycohemoglobin
[11].
While most major covariates had been considered in these
studies, the influence of diabetic duration and severity were not
consistently reported. In addition, several medical conditions (e.g.
obstructive lung disease) and disease severity that may affect
patient’s mobility were not considered. In sum, most studies
suggested that diabetes was independently associated with
functional decline, including performance-based physical function
and self-reported functional disability, among older adults. Future
studies should collect comprehensive data, utilize standardized
measurement, and recruit men and women that are more
representative of the older population to facilitate generalizability.
Falls
There were two studies that fulfilled the eligibility criteria
(table 5) [59,60]. Both suggested that DM was associated with an
increased risk of falls and recurrent falls, independent of
established fall risk factors. Moreover, both studies found that
insulin use was a major risk factor for falls.
Schwartz et al. [59] followed 9,249 women enrolled in the SOF
for 7 years. Incident falls were ascertained every 4 months by
postcard. They found that DM was associated with an increased
risk of falling. After controlled for physical performance, chronic
conditions, cardiovascular covariates, and use of sedatives or
anxiolytics, the association between non-insulin-treated diabetes
and falls was significantly attenuated (RR, 1.18 [CI, 0.87 to 1.60]).
The risk of falls comparing insulin-treated diabetic patients versus
controls remained essentially unchanged (RR, 2.76 [CI, 1.52 to
5.01]). Another prospective WHAS, recruiting 1,002 disabled
community-dwelling women aged 65 years and over, assessed
incident falls semiannually for 3 years [60]. After adjustment for
traditional risk factors and diabetes complications, women with
Table 4. Prospective studies for the association between diabetes and changes in mobility or physical function in older adults.
Source Study population
Mean age at
baseline, yr
Follow-up,
yr
Ascertainment
of diabetes
Ascertainment of
physical function Covariates
Results, RR (95% CI)
(or diabetic
individuals had
faster decline in …)
Volpato
et al, 2002
[11]
729 physically impaired
community-dwelling older
women from the Women’s
Health and Aging Study
(WHAS) (USA)
77 3 Hx, Mx, Rec,
A1c
ADLs, self-reported
ability to perform
mobility task (walking
1/4 mile, climbing steps);
physical performance
measures (usual 4-m
walking speed, 5 chair
stands, balance test)
Age, race, smoking, BMI,
depressive symptoms,
cognitive impairment,
knee OA, hip fracture,
baseline performance
score, HTN, stroke, CAD,
CHF, PVD, peripheral
nerve dysfunction, visual
impairment
Mobility disability: 1.63
(1.12–2.36)*; ADL
disability: 2.18 (1.33–
3.6){; summary
physical performance
score
Gregg et al,
2002 [56]
8344 white elder women
from the Study of
Osteoporotic Fractures
(SOF) (USA)
71.4 12 Hx, Mx Self-reported ability to
perform functional tasks
(walking 1/4 mile,
climbing 10 steps,
household chores,
shopping, and cooking
meals)
Age, marital status,
education, BMI, baseline
physical functioning,
physical activity level,
estrogen use, visual
impairment, poor
cognitive function, CAD,
stroke, depression,
arthritis
Inability to perform any
task: 1.42 (1.23–1.65)
Wu et al,
2003 [57]
1789 older Mexican
Americans from the
Sacramento Area Latino
Study on Aging (SALSA)
(USA)
70 2 Hx, Mx, FG ADLs, IADLs Age, sex, household
income, BMI, waist-to-hip
ratio, CES-D score, HTN,
stroke
ADLs, IADLs
Forrest et al,
2006 [55]
5178 white elder women
from the Study of
Osteoporotic Fractures
(SOF) (USA)
70.1 10 Hx, Mx Physical performance
measures (usual 6-m
walking speed, 5 chair
stands)
Age, weight, height,
height loss, SBP,
smoking, baseline
performance, arthritis,
ever use of thyroid
supplement or estrogen
Walking speed, time to
complete 5 chair
stands
Figaro et al,
2006 [58]
2895 well-functioning
older adults from the
Health, Aging and Body
Composition (Health ABC)
study (USA)
73.6 3.5 Hx, Mx,
FG/OGTT
Self-reported ability to
climbing 10 steps or
walking 1/4 mile
Age, sex, race, BMI,
baseline performance
score, smoking, use of
anti-inflammatory drugs,
CHF, PVD, CAD, current
estrogen use, statin use
Not significant
*336 women with severe mobility disability at baseline were excluded from the analysis.
{170 women with severe ADL disability at baseline were excluded from the analysis.
A1c indicates glycosylated hemoglobin, ABI ankle-brachial index, BMI body mass index, CAD coronary artery disease, CES-D Center for Epidemiologic Studies Depression
Scale, CHF chronic heart failure, FG fasting glucose test, HTN hypertension, Hx self-report history of diabetes or a physician’s diagnosis of diabetes, MMSE Mini-Mental
Status Examination, Mx anti-diabetes medications including insulin, NFG non-fasting glucose test, OGTT oral glucose tolerance test, Rec diabetes mellitus ascertained
from medical records, PVD peripheral vascular disease, SBP systolic blood pressure.
doi:10.1371/journal.pone.0004144.t004
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PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4144diabetes had a higher probability of any fall (RR, 1.38 [CI, 1.04 to
1.81) and of recurrent falls (RR, 1.69 [CI, 1.18 to 2.43]), compared
to women without diabetes. Risk of recurrent falls was particularly
higher among insulin-treated older women (RR, 2.73 [CI, 1.61 to
4.63]). The pooled adjusted RR for recurrent falls was 2.74 (CI,
1.85 to 4.07) when older women with insulin-treated diabetes were
compared to controls.
Although both studies suggested the relation of DM to falls,
some confounders (e.g., psychotropics use, cognition) were not
consistently adjusted. In addition, both studies had weakness in
terms of generalizability because the study population was
confined to older women. Future studies should address on
a broader sampling strategy and enroll older men as well.
Urinary Incontinence (UI)
One prospective study was identified based on our search
strategy (table 6). Lifford et al. [61] analyzed 81,845 women from
the NHS cohort who had reported information on urinary
function 4 years apart. The adjusted relative risk of incident UI
was significantly greater (RR, 1.21 [CI, 1.02 to 1.43]) in women
with DM than those without. The risk of developing very severe
UI was even more substantial in women with diabetes (RR, 1.97
[CI, 1.24 to 3.12]). They also found that the risk of incontinence
increased with the duration of DM.
The result suggested that DM was associated with higher risk of
UI in older women. However, types of UI (stress, urge, or
overflow) were not reported. Therefore it was difficult to identify
the pathophysiologic linkage between DM and incontinence. In
addition, the investigators did not take into account several
covariates, such as cognitive function and mood status, which
might interfere with the development of UI among older adults.
Future well-designed prospective studies, with standardized
definition and measurement for voiding function, are warranted
to elucidate the relationship between DM and UI.
Table 5. Prospective studies of diabetes as a risk factor for recurrent falls in community-dwelling older adults.
Source Study population
Mean age at
baseline, yr
Follow-up,
yr
Ascertainment
of diabetes
Ascertainment
of falls Covariates Results, RR (95% CI)
Schwartz et al,
2002 [59]
9249 women from the
Study of Osteoporotic
Fractures (SOF) (USA)
74 7.2 Hx, Mx Falls monitored
every 4 months
by postcard or
telephone
Age, tandem walk score,
tandem stand, loss of
pressure sensitivity, CAD,
stroke, arthritis, history of
fainting, grip strength,
positive GDS, near depth
perception, sedatives/
anxiolytics use
Non-insulin-treated
diabetes: 1.18 (0.87–1.60);
insulin-treated diabetes:
2.76 (1.52–5.01)
Volpato et al,
2005 [60]
878 community -
dwelling, disabled
women from the
Women’s Health and
Aging Study (WHAS)
(USA)
78 3 Hx, Mx, Rec,
A1c
Self report of
falls at 6
semi-annual
interviews
Age, race, education,
smoking, overweight,
obesity, hypertension, use
of anti-hypertensives,
stroke, PAD, peripheral
nerve dysfunction, knee
osteoarthritis pain categories,
visual impairment, MMSE
score, fall in 12 months prior
to baseline interview, ADL
disability, physical
performance score, knee
strength
Diabetes: 1.69 (1.18–2.43);
non-insulin-treated
diabetes: 1.34 (0.87–2.1);
insulin-treated diabetes:
2.73 (1.61–4.63)
A1c indicates glycosylated hemoglobin, ADL activity of daily living, BMI body mass index, CAD coronary artery disease, GDS Geriatric Depression Score, Hx self-report
history of diabetes or a physician’s diagnosis of diabetes, MMSE Mini-Mental Status Examination, Mx anti-diabetes medications including insulin, PAD peripheral arterial
disease, Rec diabetes mellitus ascertained from medical records, RR risk ratio.
doi:10.1371/journal.pone.0004144.t005
Table 6. Prospective studies of diabetes as a risk factor for urinary incontinence in community-dwelling older adults.
Source Study population
Mean age at
baseline, yr
Follow-up,
yr
Ascertainment
of diabetes
Ascertainment of
urinary incontinence Covariates
Results, RR
(95% CI)
Lifford
et al, 2005
[61]
53650 female nurses
from Nurses’ Health
Study (NHS) cohort
(USA)
62 4 Hx, Mx Any UI: urine leakage at least
weekly; severe UI: at least
weekly leakage of a quantity of
urine enough to wet the
underwear; very severe UI: at
least weekly leakage of a
quantity of urine enough to wet
outer clothing or the floor
Age, BMI, race,
functional status,
stroke, waist-to-hip
ratio, hysterectomy,
parity, smoking,
hormone use
Any UI: 1.21 (1.02–
1.43); severe UI: 1.40
(1.15–1.71); very severe
UI: 1.97 (1.24–3.12)
BMI indicates body mass index, Hx self-report history of diabetes or a physician’s diagnosis of diabetes, Mx anti-diabetes medications including insulin, RR risk ratio, UI
urinary incontinence.
doi:10.1371/journal.pone.0004144.t006
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We performed a systematic review of prospective population-
based studies addressing the association between DM and various
geriatric conditions among community-dwelling adults. The risk
for cognitive impairment, dementia, mobility decline, or disability
increased with diabetes compared to those without. The pooled
risk for all dementia, Alzheimer’s disease, and vascular dementia
were 1.4 to 2.4 times higher in older diabetic adults compared to
non-diabetics. Identified studies reporting the association between
DM and the incidence of falls or urinary incontinence were limited
to older women, and all indicate a positive association. Available
evidence did not suggest that DM was an independent predictor of
incident depression.
Mechanisms
There is biological evidence supporting the causality that DM
may lead to geriatric conditions. Several molecular mechanisms
have been proposed to explain the mediation between DM and
hyperglycemia-induced tissue damage, including the advanced
glycation end products (AGEs) [62]. Chronic hyperglycemia may
induce oxidative stress or through aforementioned mechanisms,
thereby causing subsequent systematic endothelial dysfunction and
diabetic vascular complications [62,63]. DM-associated metabolic
derangements, AGEs, systemic inflammation, along with tradi-
tional diabetic vascular complications, may play critical roles in
the development of geriatric conditions.
Diabetes may exert its negative impact on cognitive function
through several pathways. Hyperglycemia promotes the formation
of AGEs, which were found in senile plaques and intracellular
neurofibrillary tangles [64]. Increase or decrease in plasma glucose
concentrations can affect cognitive function [65,66]. Insulin
resistance and subsequent hyperinsulinemia also contribute.
Insulin inhibits the degradation of beta-amyloid (the main product
of the AD process) through competitive inhibition of insulin-
degrading enzyme in the brain, thus increasing amyloid protein
deposition in plaques [67]. Hyperinsulinemia may also activate
inflammatory network in the periphery and the brain, thereby
increases the risk of AD [67]. DM-related vasculopathy in the
brain may lead to lacunes, leukoariosis, large artery ischemic
stroke, and cortical atrophy. These structural changes are known
to be risk factors for cognitive dysfunction and dementia.
Diabetes may affect physical performance in older adults
through several mechanisms. In animal studies, non-enzymatic
glycation alters the structures and functions of myosin and actins,
which further interfere with muscle contraction [69–72]. In
addition, hyperglycemia- induced chronic inflammation status
exerts negative impact on skeletal muscle function [73,74]. These
were in line with clinical observations that older diabetic adults
have poorer muscle quality compared with their non-diabetic
counterparts, and lose their muscle strength and quality more
rapidly, especially those with longer disease duration and poorer
glycemic control [75]. Furthermore, cerebral vasculopathy,
peripheral artery disease, peripheral polyneuropathy, autonomic
neuropathy, and retinopathy are also responsible for the mobility
limitations and falls among older adults with diabetes.
The effect of DM on voiding function is more complex, which
may involve pathophysiological changes in the detrusor muscle,
urothelium, central and autonomic nervous systems, and blood
supply to the bladder [76]. Hyperglycemia may cause an increased
volume of urine, polyuria, or detrusor instability. Additionally,
diabetes may contribute to the development of urinary in-
continence through associated cognitive dysfunction, functional
limitation, or medical comorbidities, even though the lower
urinary tract is intact. Hence the impact of DM on urinary
incontinence is likely multi-factorial.
Strengths and Limitations
To our knowledge, the present review is the first one that
summarizes prospective data relating DM to geriatric conditions.
Cukierman and colleagues conducted a systematic review of
prospective studies to examine the relationship between DM and
changes in cognitive function [77]. They found that people with
diabetes have a greater rate of cognitive decline and an increased
risk of future dementia (RR, 1.6 [CI, 1.4 to 1.8]), which was
concordant with our results. However, studies conducted in
a historical cohort or with questionable baseline diabetes
ascertainment were included in their analysis.
In this review, we included only prospectively-designed studies
exploring the causal relationship of DM to various aging
phenotypes. Therefore, the temporal relationship was appropriate
(i.e. DM preceded the incidence of geriatric conditions). In
addition, studies with questionable DM ascertainment were
excluded in order to minimize misclassification of patients.
Because there are also possible non-causal explanations for the
association between DM and geriatric conditions, we excluded
studies without appropriate adjustment for potential confounders,
especially cardiovascular comorbidities. Hence the results provide
more precise estimates of the impact of DM on older adults.
Our searches did not include conference papers and thesis,
which may bring a selection bias. Geriatric syndromes are
complex multi-factorial problems. Cognitive status, mobility,
sensory function, and psychosocial status of older adults are all
crucial to the development of geriatric conditions. Nevertheless,
not all included studies have thoroughly considered these factors.
In addition, studies included in our review did not consistently
report disease-related factors, such as duration of DM, status of
glycemic control, and treatment. These factors may confound the
outcomes of interest. Finally, literatures regarding DM to several
outcomes (e.g., falls and UI) were limited to older women, hence
the generalizability was limited.
Future Implications
The evidence supported that older diabetic adults have an
increased risk for selected multi-system aging phenotypes, which
were associated with substantial morbidity and adverse outcomes
among older population [18]. In addition, some of the problems
(e.g., cognitive dysfunction, mobility impairment) may significantly
interfere with disease management [78,79]. While physicians try to
do their best to manage DM in older adults, this additional
evidence may encourage increased awareness, management and
patient education in their daily practice.
Future research should attempt to explore the underlying
mechanisms linking DM to geriatric conditions, and address
complex interaction between risk factors. DM as a shared risk
factors across different geriatric conditions raises the possibility of
shared pathophysiological mechanisms across aging phenotypes,
such as AGEs formation, oxidative stress, systemic inflammation,
and vasculopathy. On the other hand, test of causal relationship
can only rely on interventional studies showing that intensive
glycemic control can prevent or delay the incidence of geriatric
conditions. However, given that older adults are more vulnerable
to adverse effect of strict glucose control, modification of other
cardiovascular factors may be an alternative. Prior investigation
has confirmed the benefit of tight blood pressure control on
cardiovascular disease risk reduction among patients with type 2
diabetes [80]. Angiotensin-converting-enzyme (ACE) inhibitors
and statins are also promising in vasculoprotective effect among
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needed to determine whether these therapies alone or in
combination could reduce or delay the development of multi-
system aging phenotypes.
Conclusion
Despite methodological limitations of the observational studies
reviewed, the consistency of reported relationship between DM
and selected geriatric conditions among community-dwelling older
adults across studies support the proclaim that DM is a major risk
factor for multi-system aging phenotypes. Primary care physician
should be aware and appropriately manage these problems.
Future research is required to elucidate the underlying patholog-
ical pathway linking DM to geriatric conditions. Interventional
studies with glucose-lowering therapy are needed to test the
hypotheses that intensive glycemic control can reduce adverse
geriatric outcomes.
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